• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Tatva Chintan Pharma Chem Limited — Board Meeting, 31-10-2025: Outcome of Board Meeting

    31-10-2025 | 03:44 pm

    Tatva Chintan Pharma Chem's board approved the consolidated financial results for the quarter and half-year ended September 30, 2025, reporting a Q2 profit of ₹6.65 Cr and H1 profit of ₹16.57 Cr. Mr. Ajesh Kumar Mohanan Pillai was appointed as the new Chief Financial Officer.

    No comments yet. Be the first to comment!

    All announcements from Tatva Chintan Pharma Chem Limited